EDGAR Filing Documents for 0001193125-09-174561

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-09-174561

Filing Date

2009-08-13

Accepted

2009-08-13 17:28:15

Documents

Period of Report

2009-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d10q.htm	10-Q	340479
2	SERVICES AGREEMENT - TWO RIVER CONSULTING, LLC	dex102.htm	EX-10.2	86481
3	CERTIFICATION OF CEO PURSUANT TO RULE 13A-15(E)/15D-15(E)	dex311.htm	EX-31.1	5593
4	CERTIFICATION OF CFO PURSUANT TO RULE 13A-15(E)/15D-15(E)	dex312.htm	EX-31.2	5600
5	CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350	dex321.htm	EX-32.1	3528
6	CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350	dex322.htm	EX-32.2	3532
	Complete submission text file	0001193125-09-174561.txt		446723

Mailing Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104

Business Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104 (415) 875-7880

Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)